131 related articles for article (PubMed ID: 10764847)
1. Combining insulin and oral agents.
Buse J
Am J Med; 2000 Apr; 108 Suppl 6a():23S-32S. PubMed ID: 10764847
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
3. Combining sulfonylureas and other oral agents.
Riddle M
Am J Med; 2000 Apr; 108 Suppl 6a():15S-22S. PubMed ID: 10764846
[TBL] [Abstract][Full Text] [Related]
4. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.
Janka HU; Plewe G; Riddle MC; Kliebe-Frisch C; Schweitzer MA; Yki-Järvinen H
Diabetes Care; 2005 Feb; 28(2):254-9. PubMed ID: 15677775
[TBL] [Abstract][Full Text] [Related]
5. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
Takamatsu J
Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
[No Abstract] [Full Text] [Related]
6. Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Acta Clin Belg; 1993; 48(4):259-68. PubMed ID: 8212978
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Clinical inquiries. What is the role of combination therapy (insulin plus oral medication) in type 2 diabetes?
Eskesen S; Kelsberg G; Hitchcock K; Lo V
J Fam Pract; 2006 Nov; 55(11):1001-3. PubMed ID: 17090364
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
10. The UK Prospective Diabetes Study.
Kerner W
Lancet; 1998 Dec; 352(9144):1934. PubMed ID: 9863811
[No Abstract] [Full Text] [Related]
11. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
[TBL] [Abstract][Full Text] [Related]
12. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
Ravina A; Minuchin O
Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
[No Abstract] [Full Text] [Related]
13. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
Yki-Järvinen H
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
[TBL] [Abstract][Full Text] [Related]
14. Timely addition of insulin to oral therapy for type 2 diabetes.
Riddle MC
Diabetes Care; 2002 Feb; 25(2):395-6. PubMed ID: 11815517
[No Abstract] [Full Text] [Related]
15. Combination oral agent and insulin therapy for type 2 diabetes mellitus.
Passaro MD; Ratner RE
Curr Diab Rep; 2001 Oct; 1(2):106-11. PubMed ID: 12643105
[TBL] [Abstract][Full Text] [Related]
16. Combination sulfonylurea and insulin therapy in non-insulin-dependent diabetes mellitus.
Collo MB; Johnson JL; Kabadi UM
Nurse Pract; 1993 Jul; 18(7):40, 43-4, 47-8. PubMed ID: 8351085
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
Ekström N; Svensson AM; Miftaraj M; Franzén S; Zethelius B; Eliasson B; Gudbjörnsdottir S
Diabetes Obes Metab; 2016 Oct; 18(10):990-8. PubMed ID: 27282621
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy of diabetes mellitus].
Kaneko T
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):406-9. PubMed ID: 8315336
[No Abstract] [Full Text] [Related]
19. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
[TBL] [Abstract][Full Text] [Related]
20. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
